Skip to Main Content

Skip Nav Destination

Letter| December 18, 2025

Real world comparison of progression free survival and time to next therapy in 761 newly diagnosed multiple myeloma patients

Hira Mian,

Hira Mian

McMaster University, Hamilton, Ontario, Canada

* Corresponding Author; email: hira.mian@medportal.ca

Search for other works by this author on:

PubMed

Google Scholar

Mariano Arribas,

Mariano Arribas

Mayo Clinic, Phoenix, Arizona, United States

https://orcid.org/0000-0003-1859-7098

Search for other works by this author on:

PubMed

Google Scholar

Rafael Fonseca,

Rafael Fonseca

Mayo Clinic, Phoenix, Arizona, United States

Search for other works by this author on:

PubMed

Google Scholar

Erin Mutterback,

Erin Mutterback

The Ottawa Hospital, Ottawa, Ontario, Canada

https://orcid.org/0009-0000-6431-4226

Search for other works by this author on:

PubMed

Google Scholar

Omar Shahid,

Omar Shahid

McMaster University, Hamilton, Ontario, Canada

Search for other works by this author on:

PubMed

Google Scholar

Rohan Gouda,

Rohan Gouda

McMaster University, Hamilton, Ontario, Canada

Search for other works by this author on:

PubMed

Google Scholar

Gregory Russell Pond,

Gregory Russell Pond

McMaster University, Hamilton, Ontario, Canada

https://orcid.org/0000-0003-1033-0882

Search for other works by this author on:

PubMed

Google Scholar

Alissa Visram

Alissa Visram

The Ottawa Hospital, Ottawa, Ontario, Canada

https://orcid.org/0000-0002-7201-4642

Search for other works by this author on:

PubMed

Google Scholar

Blood Adv bloodadvances.2025018655.

https://doi.org/10.1182/bloodadvances.2025018655

This content is only available as a PDF.

Copyright © 2025 American Society of Hematology

2025

Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Supplemental data